158 related articles for article (PubMed ID: 37771000)
21. Treatment advances for pediatric and adult onset neoplasms with monocytosis.
McCullough KB; Kuhn AK; Patnaik MM
Curr Hematol Malig Rep; 2021 Jun; 16(3):256-266. PubMed ID: 33728588
[TBL] [Abstract][Full Text] [Related]
22. Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.
Chang TY; Dvorak CC; Loh ML
Blood; 2014 Oct; 124(16):2487-97. PubMed ID: 25163700
[TBL] [Abstract][Full Text] [Related]
23. Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations.
Yoshimi A; Kojima S; Hirano N
Paediatr Drugs; 2010; 12(1):11-21. PubMed ID: 20034338
[TBL] [Abstract][Full Text] [Related]
24. DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.
Flotho C; Sommer S; Lübbert M
Semin Cancer Biol; 2018 Aug; 51():68-79. PubMed ID: 29129488
[TBL] [Abstract][Full Text] [Related]
25. Juvenile myelomonocytic leukemia presenting with features of neonatal hemophagocytic lymphohistiocytosis and cutaneous juvenile xanthogranulomata and successfully treated with allogeneic hemopoietic stem cell transplant.
Arachchillage DR; Carr TF; Kerr B; Hawkins K; Kelsey A; Judge M; Wynn RF
J Pediatr Hematol Oncol; 2010 Mar; 32(2):152-5. PubMed ID: 20168243
[TBL] [Abstract][Full Text] [Related]
26. [Clinical features and prognosis of juvenile myelomonocytic leukemia: an analysis of 63 cases].
Yang WY; Liu LP; Liu F; Qi BQ; Chang LX; Zhang L; Chen XJ; Zou Y; Chen YM; Guo Y; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):265-271. PubMed ID: 36946161
[TBL] [Abstract][Full Text] [Related]
27. Molluscum Mimicker: Juvenile Xanthogranulomas with Associated Juvenile Myelomonocytic Leukemia.
Boyd A; Newman J; Turcotte L; Polcari IC
J Pediatr; 2016 Oct; 177():326-326.e1. PubMed ID: 27514241
[No Abstract] [Full Text] [Related]
28. Diagnosis and treatment of juvenile myelomonocytic leukemia.
Liao XY; Qiu KY; Fang JP; Wu RH; Guo SY; Huang K; Zhou DH
Hematology; 2019 Dec; 24(1):577-582. PubMed ID: 31389303
[No Abstract] [Full Text] [Related]
29. [Juvenile myelomonocytic leukemia and pediatric myelodysplastic syndromes].
Strullu M; Leblanc T; Lainey E
Bull Cancer; 2023 Nov; 110(11):1183-1195. PubMed ID: 37453833
[TBL] [Abstract][Full Text] [Related]
30. Primary Graft Failure but Treatment Success: A Case of Reversion to Heterozygosity After Allogeneic Hematopoietic Cell Transplantation With Autologous Hematopoietic Recovery in a Child With CBL-related Juvenile Myelomonocytic Leukemia.
Oshrine B
J Pediatr Hematol Oncol; 2021 Apr; 43(3):e426-e428. PubMed ID: 32032248
[TBL] [Abstract][Full Text] [Related]
31. [Successful second allogeneic hematopoietic stem cell transplantation with azacitidine as bridging therapy for relapsed juvenile myelomonocytic leukemia].
Oshiro T; Hyakuna N; Abe H; Hamada S; Nakanishi K
Rinsho Ketsueki; 2023; 64(3):187-192. PubMed ID: 37019671
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of juvenile myelomonocytic leukemia patients after sequential therapy with cytarabine and 6-mercaptopurine.
Wajid M A; Gupta AK; Das G; Sahoo D; Meena JP; Seth R
Pediatr Hematol Oncol; 2020 Oct; 37(7):573-581. PubMed ID: 32459546
[TBL] [Abstract][Full Text] [Related]
33. [Genetic characteristics and survival analysis of 27 cases of juvenile myelomonocytic leukemia].
Li JJ; Hu T; Li JH; Zhang ZX; Feng SQ; Shi XD; Zhang L; Cao J; Song ZL; Hu MZ; Zhong DX; Yue M; Fan W; Tang RH; Zou BH; Liu R
Zhonghua Er Ke Za Zhi; 2023 Jan; 61(1):56-60. PubMed ID: 36594122
[No Abstract] [Full Text] [Related]
34. Human leukocyte antigen disparities reduce relapse after hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: A single-center retrospective study from China.
Lin YC; Luo CJ; Miao Y; Wang JM; Luo CY; Qin X; Cai JY; Li BS; Chen J
Pediatr Transplant; 2021 Mar; 25(2):e13825. PubMed ID: 33131184
[TBL] [Abstract][Full Text] [Related]
35. Intestinal Behçet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation: A case report.
Asano T; Sato S; Furuya MY; Takahashi H; Shichishima-Nakamura A; Ohkawara H; Fujiwara T; Gunji N; Hashimoto C; Momma T; Saito M; Nakano H; Watanabe G; Temmoku J; Fujita Y; Matsuoka N; Kobayashi H; Watanabe H; Mouri M; Mashiyama F; Sakuma H; Ohira H; Mori M; Ikezoe T; Migita K
Medicine (Baltimore); 2019 Nov; 98(46):e17979. PubMed ID: 31725663
[TBL] [Abstract][Full Text] [Related]
36. Targeted therapy in juvenile myelomonocytic leukemia: Where are we now?
De Vos N; Hofmans M; Lammens T; De Wilde B; Van Roy N; De Moerloose B
Pediatr Blood Cancer; 2022 Nov; 69(11):e29930. PubMed ID: 36094370
[TBL] [Abstract][Full Text] [Related]
37. Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.
Patel SA; Coulter DW; Grovas AC; Gordon BG; Harper JL; Warkentin PI; Wisecarver JL; Sanger WG; Coccia PF
J Pediatr Hematol Oncol; 2014 Aug; 36(6):491-4. PubMed ID: 24322499
[TBL] [Abstract][Full Text] [Related]
38. Controversies of and unique issues in hematopoietic cell transplantation for infant leukemia.
Hunger SP; Loh KM; Baker KS; Schultz KR
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):79-83. PubMed ID: 19147083
[TBL] [Abstract][Full Text] [Related]
39. Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.
Niemeyer CM; Flotho C; Lipka DB; Starý J; Rössig C; Baruchel A; Klingebiel T; Micalizzi C; Michel G; Nysom K; Rives S; Schmugge Liner M; Zecca M; Schönung M; Baumann I; Nöllke P; Benettaib B; Biserna N; Poon J; Simcock M; Patturajan M; Menezes D; Gaudy A; van den Heuvel-Eibrink MM; Locatelli F
Blood Adv; 2021 Jul; 5(14):2901-2908. PubMed ID: 34297046
[TBL] [Abstract][Full Text] [Related]
40. Different outcomes of allogeneic hematopoietic stem cell transplant in a pair of twins affected by juvenile myelomonocytic leukemia.
Cesaro S; De Filippi P; Di Meglio A; Leszl A; Donska S; Zaccaron A; Cagioni C; Galavotti R; Danesino C; Aprili F; Cugno C; te Kronnie G; Zecca M; Bresolin S
Int J Hematol; 2014 Feb; 99(2):208-12. PubMed ID: 24338706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
